Related Experiment Video
Updated: Nov 4, 2025

Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
Prevalence of severe cardiovascular disease in patients with schizophrenia
J-C Marche1, A Bannay2, S Baillot2
1Psychiatry and Clinical Psychology Service (G06), Psychotherapeutic Center of Nancy, 1, rue Dr-Archambault, BP 11010, 54521 Laxou cedex, France; University of Lorraine, Lorraine, France.
Insights
Patients with schizophrenia experience severe cardiovascular disease (CVD) at younger ages. This study highlights the high prevalence of CVD risk factors in this population, emphasizing the need for early screening and intervention.
Area of Science:
- Cardiology
- Psychiatry
- Public Health
Background:
- Schizophrenia is associated with increased cardiovascular disease (CVD) risk.
- Understanding the prevalence and early onset of severe CVD in schizophrenia patients is crucial for public health initiatives.
Purpose of the Study:
- To determine the prevalence of severe cardiovascular disease (CVD) requiring hospitalization in patients diagnosed with schizophrenia in France.
- To identify associated cardiovascular risk factors in this patient group.
Main Methods:
- A retrospective study included 4424 patients hospitalized with schizophrenia in five French psychiatric hospitals in 2015.
- Cardiovascular disease (CVD) was identified via ICD-10 codes for myocardial infarction, stroke, heart failure, coronary artery disease, or peripheral artery disease up to five years prior and three years after psychiatric hospitalization.
- Prevalence of hypertension, obesity, and diabetes was recorded.
Main Results:
- Overall, 4.6% of patients with schizophrenia were diagnosed with severe cardiovascular disease (CVD).
- Specific CVD prevalence included coronary artery disease (2.1%), heart failure (1.9%), and stroke (1.1%).
- High prevalence of risk factors was observed: hypertension (11.3%), obesity (9.7%), and diabetes (7.8%).
Conclusions:
- Patients with schizophrenia develop severe cardiovascular disease (CVD) requiring hospitalization at an earlier age compared to the general population.
- The high co-occurrence of CVD and risk factors underscores the need for proactive cardiovascular health management in schizophrenia care.
- Early screening and management of CVD and its risk factors are essential to improve life expectancy and quality of life for individuals with schizophrenia.
Objectives:
We assessed the prevalence of severe cardiovascular (CV) disease requiring hospitalization among patients with schizophrenia in France.
Method:
We included patients hospitalized with schizophrenia or psychotic disorder during 2015, in five French psychiatric hospitals. Patients with CV disease were defined as those with a correspondent ICD-10 code during a hospital stay in any general hospital, five years before or three years after the psychiatric hospitalization. CV disease included myocardial infarction (MI), stroke, heart failure (HF), coronary artery disease (CAD) or peripheral artery disease. Risk factors such as hypertension, obesity and diabetes were recorded.
Results:
In total, 4424 patients with schizophrenia were included. Overall, 203 (4,6%) patients were diagnosed with CV disease, 93 (2.1%) with CAD, 86 (1.9%) with HF and 49 (1.1%) with stroke. The prevalence of hypertension, obesity and diabetes was 11.3%, 9.7% and 7.8%. The median (interquartile range) age of patients with MI and diabetes was 57 (49-70) and 56 (48-66) years.
Conclusion:
Patients with schizophrenia develop severe CV disease requiring hospitalization at an early age. These severe events are associated with a high prevalence of risk factors. Early screening and treatment of CV disease and risk factors is important to improve life expectancy and quality of life of these patients.
More Related Videos
08:04Derivation, Expansion, Cryopreservation and Characterization of Brain Microvascular Endothelial Cells from Human Induced Pluripotent Stem Cells
Published on: November 19, 2020
05:14Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
Published on: September 8, 2021
Related Concept Videos
Schizophrenia
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Psychological and Sociocultural Causes of Schizophrenia
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Coronary Artery Disease III: Clinical Manifestations
Cardiomyopathy III: Hypertrophic Cardiomyopathy